Charles River Laboratories CRL Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The official record: Charles River Laboratories’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Charles River Laboratories's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Charles River Laboratories's accounts payable?
- Charles River Laboratories (CRL) reported accounts payable of $133.95M in Q1 2026.
- How has Charles River Laboratories's accounts payable changed year-over-year?
- Charles River Laboratories's accounts payable decreased by 10.3% year-over-year, from $149.33M to $133.95M.
- What is the long-term trend for Charles River Laboratories's accounts payable?
- Over 5 years (2020 to 2025), Charles River Laboratories's accounts payable has grown at a 4.0% compound annual growth rate (CAGR), from $122.48M to $148.8M.
- What does accounts payable mean?
- Money the company owes to its suppliers for goods and services.
- How do you interpret accounts payable?
- An increase can signal improved cash management or delayed payments, while a decrease may indicate faster settlement of obligations.
- How does accounts payable compare across companies?
- Typically benchmarked against days payable outstanding (DPO) to compare payment terms across industry peers.